Alpha Teknova Inc TKNO
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $8.90
- Day Range
- $8.75–9.11
- 52-Week Range
- $1.91–9.48
- Bid/Ask
- $8.18 / $9.50
- Shares Outstanding
- 53.69M
- Market Cap
- $475.68M
- Volume/Avg
- 344,324 / 219,546
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 10.89
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 158
- Website
- https://www.teknova.com
Valuation
|
Metric
|
TKNO
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 10.89 |
Price/Cash Flow | — |
Price/Earnings
TKNO
Financial Strength
|
Metric
|
TKNO
|
|---|---|
Quick Ratio | 3.32 |
Current Ratio | 4.49 |
Interest Coverage | −18.12 |
Quick Ratio
TKNO
Profitability
|
Metric
|
TKNO
|
|---|---|
Return on Assets (Normalized) | −13.95% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −14.10% |
Return on Assets
TKNO
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|SdFFwSLg | LOCK|V&&q? | $66B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|?Jc#!Z@T | LOCK|zHX%k | $46B | |||
| Haleon PLC ADR
HLN
| LOCK|HF$@>ZV | LOCK|dw! | $38B | |||
| Zoetis Inc Class A
ZTS
| LOCK|%<<@n?>> | LOCK|&@ | $29B | |||
| Viatris Inc
VTRS
| LOCK|l$sXGZk | LOCK|wQx | $20B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|$r | LOCK|c& | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|&hfG!$ | LOCK|!XV | $10B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|^rnrb!> | LOCK|sX@ | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|vZ!<nlb | LOCK|#Rgb | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|&P&<PdS | LOCK|S!w | $2B |
United States